Search clinical trials for: Reference Treatment: 5 mg amlodipine 50 mg losartan

Total 208 results

University Health Network, Toronto

Active, not recruiting

Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis (BIOTAPE)

Axial Spondyloarthritis

Canada
Cingulate Therapeutics

Completed

CTx-1301 Comparative Bioavailability Study

ADHD

United States
GlaxoSmithKline

Completed

Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health Volunteers

Hypertension

Australia
Novartis Pharmaceuticals

Recruiting

Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy

Hypertension

Japan
IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg

Fasting

India
Novartis

Completed

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension (ACADEMY)

Stage II Hypertension

Thailand
Bio-innova Co., Ltd

Not yet recruiting

Sitagliptin and Metformin Hydrochloride Tablets 50 mg/500 mg Relative to Originator

Healthy Subjects
AIO-Studien-gGmbH
Taiho Pharmaceutical Co., Ltd.; Nordic Pharma SAS

Completed

Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer (MATEO)

Esophageal Neoplasms | Gastric Adenocarcinoma | Esophageal Adenocarcinoma | Gastroesophageal Junction Adenocarcinoma | Gastric Neoplasm | Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

Germany
Novartis

Completed

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

Hypertension

China
HK inno.N Corporation

Unknown

Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan (MACH)

Hypertension

Korea, Republic of
Damanhour University

Completed

Ivabradine in Patients With Congestive Heart Failure

Congestive Heart Failure

Egypt
Spanish Clinical Pharmacology Society
Spanish reumatology Society

Completed

Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF (REDES-TNF)

Spondylarthropathies

Spain
The Affiliated Hospital of Qingdao University

Completed

Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese Subjects

Healthy Subjects

China
Astellas Pharma Europe Ltd.

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) (BESIDE)

Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
Radboud University Medical Center
Netherlands Heart Foundation

Completed

VITRO-Trial. B Vitamins and the Secondary Prevention of Venous Thrombosis

Pulmonary Embolism | Deep-Vein Thrombosis

Netherlands
Pharmtechnology LLC

Recruiting

Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Boehringer Ingelheim

Completed

Open Label Study Telmisartan and Amlodipine in Hypertension

Hypertension

Belgium, Canada, Denmark, Finland, France, Korea, Republic of, Netherlands, Norway, Philippines, South Africa, Sweden, Taiwan
Ain Shams University
Drug Research Centre, Cairo, Egypt

Completed

A Comparative Pharmacokinetic and Pharmacodynamic Study of Sildenafil in Adult Smokers and Non Smokers

Smoking | Erectile Dysfunction | Pharmacokinetics | Pharmacodynamics

Egypt
Neutec Ar-Ge San ve Tic A.Ş

Completed

Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension Patients

Hypertension

Turkey
University of Alberta

Recruiting

The Impact of Sildenafil on the Pulmonary Circulation in Healthy Trained and Untrained Humans

Healthy

Canada
Italo Biaggioni
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

Obesity-Associated Insulin Resistance

United States
GlaxoSmithKline
Hammersmith Medicines Research; Covance Harrogate

Completed

A Phase 1 Relative Bioavailability Study of Ambrisentan and Tadalfil Fixed Dose Combination Tablets in Healthy Subjects

Hypertension, Pulmonary

United Kingdom
IBSA Institut Biochimique SA

Recruiting

A New Sildenafil Oral Film in Patients With Erectile Dysfunction

Erectile Dysfunction

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo

Migraine With or Without Aura
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study

Migraine With or Without Aura
Montreal Heart Institute
Pfizer

Terminated

High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients

Hypertension

Canada
Idorsia Pharmaceuticals Ltd.

Completed

Dose-finding Study With ACT-132577 (Aprocitentan) in Participants With Essential Hypertension

Essential Hypertension

United States, Canada, Israel, Puerto Rico
Merck Sharp & Dohme LLC

Completed

A Study Comparing the Pharmacokinetic and Pharmacodynamic Profiles for Sitagliptin, Saxagliptin and Vildagliptin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-142)

Type 2 Diabetes Mellitus
Antares Pharma Inc.

Completed

Pharmacokinetic Study of Testosterone Enanthate

Hypogonadism

United States
Seoul National University Hospital

Unknown

Effect of Lacidipine and Losartan on 24 Hour Systolic Blood Pressure Variability in Elderly Hypertensive Patients

Hypertension

Korea, Republic of
ViiV Healthcare
GlaxoSmithKline

Completed

Bioavailability Study of 10 Milligram (mg) and 5 mg Tablets Versus Conventional Tablets of Dolutegravir

HIV Infections

United States
AstraZeneca
St. John's Research Institute

Completed

A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components (MARS)

Primary Hypertension

India
Boehringer Ingelheim

Completed

Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)

Hypertension

Japan
Novartis Pharmaceuticals

Completed

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

Hypertension

Czech Republic, Finland, France, Germany, Hungary, Italy, Poland, Slovakia, Spain, Sweden
Novartis Pharmaceuticals

Completed

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

Hypertension

China
Shanghai Jiao Tong University School of Medicine

Recruiting

Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension

Isolated Systolic Hypertension

China
Research Institute for Complex Problems of Cardiovascular...

Completed

Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter Ablation

Atrial Fibrillation
University Hospital, Montpellier

Withdrawn

Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility Index (AMLODIP)

Frozen Embryo Transfer

France
Cytokinetics

Recruiting

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM (MAPLE-HCM)

Obstructive Hypertrophic Cardiomyopathy (oHCM)

United States, Denmark, Spain, Netherlands, United Kingdom, Germany, France, China, Israel, Italy, Hungary, Canada
AstraZeneca
Quotient Sciences

Completed

Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects

Cardiovascular Disease

United Kingdom
HK inno.N Corporation

Completed

Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination Tablets (REVERT-K)

Hypertension, Hyperlipidemia

Korea, Republic of
University of Roma La Sapienza

Completed

Cardiovascular Effects of Chronic Sildenafil in Men With Type 2 Diabetes (CECSID)

Diabetes Mellitus, Type 2 | Endothelial Dysfunction

Italy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors (EXCEL)

Hypertension and Cardiovascular Risk Factors
Janssen Research & Development, LLC

Terminated

A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNFα Naive Participants With Active Radiographic Axial Spondyloarthritis

Axial Spondyloarthritis

United States, Ukraine, Taiwan, Poland, Korea, Republic of, Russian Federation, Czechia
Assistance Publique Hopitaux De Marseille

Unknown

Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS (COVIDANCE)

COVID-19 | ARDS

France
GlaxoSmithKline

Completed

The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult Patients

Hypertension | Uncomplicated Hypertension | Essential

Taiwan
Daewoong Pharmaceutical Co. LTD.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

Hypertension | Dyslipidemias

Korea, Republic of
Hawler Medical University

Completed

Tranexamic Acid for the Prevention of Blood Loss in High Risk Delivered Women

Postpartum Hemorrhage | High Risk Pregnancy | Tranexamic Acid | Third-Stage Postpartum Hemorrhage, With Delivery

Iraq
GlaxoSmithKline

Completed

Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents

Migraine Disorders

Japan
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Metolazone Tablets 5 mg and Zaroloxyn® Tablets 5 mg

Healthy

United States

Search clinical trials for: Reference Treatment: 5 mg amlodipine 50 mg losartan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations